<DOC>
	<DOCNO>NCT00307671</DOCNO>
	<brief_summary>The aim trial low morbidity rate elderly patient affect systemic necrotizing vasculitides , reduce mortality improve global outcome .</brief_summary>
	<brief_title>Treatment Necrotizing Vasculitides Patients Older Than 65 Years</brief_title>
	<detailed_description>Systemic necrotizing vasculitides severe disease associate high mortality rate elderly . Although corticosteroids immunosuppressant effective , induce side-effects , especially latter patient . Preliminary data indicate systemic necrotizing vasculitides ( SNV ) occur patient 65 year poorer outcome young patient ( mortality rate 76 % vs. 69 % 5 year , respectively ) 68,4 % elderly experience treatment side-effects . In trial , patient randomly assign receive either low dos corticosteroid systematically combination immunosuppressant ( CYC azathioprine ) usual regimen corticosteroid combine immunosuppressant factor ( ) poor prognosis present ( latter regimen rely previously publish therapeutic guideline ) .</detailed_description>
	<mesh_term>Vasculitis</mesh_term>
	<mesh_term>Granulomatosis Polyangiitis</mesh_term>
	<mesh_term>Systemic Vasculitis</mesh_term>
	<mesh_term>Churg-Strauss Syndrome</mesh_term>
	<mesh_term>Microscopic Polyangiitis</mesh_term>
	<mesh_term>Polyarteritis Nodosa</mesh_term>
	<mesh_term>Cyclophosphamide</mesh_term>
	<mesh_term>Methotrexate</mesh_term>
	<mesh_term>Azathioprine</mesh_term>
	<mesh_term>Mycophenolate mofetil</mesh_term>
	<mesh_term>Prednisone</mesh_term>
	<mesh_term>Mycophenolic Acid</mesh_term>
	<mesh_term>Methylprednisolone Hemisuccinate</mesh_term>
	<mesh_term>Prednisolone</mesh_term>
	<mesh_term>Prednisolone acetate</mesh_term>
	<mesh_term>Methylprednisolone acetate</mesh_term>
	<mesh_term>Methylprednisolone</mesh_term>
	<mesh_term>Prednisolone hemisuccinate</mesh_term>
	<mesh_term>Prednisolone phosphate</mesh_term>
	<criteria>Newly diagnose WG , MPA , PAN without HBV infection , CSS Patients still enrol within 1 month start corticosteroid prescribe accord protocol . within 65th anniversary Age â‰¥ 65 year Any cytotoxic drug within previous year Coexistence another systemic autoimmune disease , e.g. , SLE , RA Virusassociated vasculitides HIV positivity Malignancy ( usually exclude unless approve trial coordinator ) Age &lt; 65 year Inability give inform consent</criteria>
	<gender>All</gender>
	<minimum_age>65 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>March 2007</verification_date>
	<keyword>Systemic necrotizing vasculitides</keyword>
	<keyword>corticosteroid ; azathioprine ; mycophenolate mofetil ;</keyword>
	<keyword>cyclophosphamide</keyword>
	<keyword>Elderly patient</keyword>
	<keyword>Randomized control trial</keyword>
</DOC>